Hood River Capital Management LLC
Q3 2022 13F-HR Holdings
Net value change ($000)
+99,542
(4.0%)
New positions
26
Sold out positions
27
Turnover %
27.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CALX | 47,631 | 131.9% |
| EXLS | 37,779 | 141.3% |
| BHVN | 36,888 | NEW |
| AYXGBX | 36,373 | NEW |
| Karuna Therapeutics, Inc. | 35,462 | 225.8% |
| GTLS | 29,490 | 29.4% |
| NUVASIVE INC | 27,583 | NEW |
| AXON | 25,879 | 65.9% |
| GTM | 23,470 | 60.2% |
| DCGO | 23,086 | 113.1% |
Top Reduces (Value $000, Stocks/ETFs)
| PRKS | -52,718 | -100.0% |
| ONTO | -47,497 | -59.8% |
| Franchise Group, Inc. | -44,645 | -100.0% |
| Biohaven Pharmaceutical Holding Co Ltd. | -34,777 | -100.0% |
| ChemoCentryx, Inc. | -33,125 | -100.0% |
| SAFE | -30,226 | -100.0% |
| SITM | -23,348 | -100.0% |
| TNDM | -22,650 | -100.0% |
| ENOV | -21,802 | -100.0% |
| ESAB | -17,350 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|